Deval L. Patrick, Director at Global Blood Therapeutics, Inc. (GBT), sold 84,758 shares at $43.40 ($3.7M) on 2018-07-06, disclosed to the SEC on 2018-07-10.
Open-market sale of $3.7M GBT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.40 | 42,379 | $1.8M | 50.0% |
| 2 | $43.40 | 42,379 | $1.8M | 50.0% |
| Total | $43.40 avg | 84,758 | $3.7M | 100% |
| Filing → |
| CERE | SELL | 2023-11-03 | $753K | — | Filing → |
| CERE | SELL | 2022-09-14 | $2.9M | — | Filing → |
| AMWL | BUY | 2022-04-22 | $198K | — | Filing → |